Huons announced on the 13th that it has signed an export contract with Canadian pharmaceutical company Formative Pharma Inc (FPI). Items signed an export contract are▲1% Lidocaine hydrochloride injection 5mL, ▲ 0.75% Bupivacaine hydrochloride injection 2ml, and ▲ 1% lidocaine hydrochloride injection 5mL vial. These items were obtained from April 2018 to May 2020 by the U.S. Food and Drug Administration (FDA). Huons plans to work with FPI to obtain permission from Health Canada. It is expected that it will be able to complete the license application by June and start local sales within the third quarter of next year.

"The Canadian generic basic injection market is worth $712 million, of which Huons en